Eight people died in France because of thrombosis arising after vaccination from Coronavirus drug from Astrazeneca. This is reported by the National Medicine Safety Agency (ANSM), reports news.
As of April 8, more than 2.72 million vaccinations of Astrazeneca were made in France. From April 2 to April 8, nine new cases atypical on its localization of thrombosis and two cases of isolated disseminated intravascular coagulation were found.
In total, from the beginning of the vaccination of the population of the country from COVID-19, 23 cases of thrombosis were recorded in France. Eight of them turned out to be fatal.
Earlier, Denmark became the first European country, which completely refused the Vaccine of the British-Swedish company Astrazeneca. The authorities of the country on the basis of scientific findings concluded that there is a real risk of serious side effects associated with the use of the drug.
A number of European countries have been suspended or partially banned vaccination with Astrazeneca due to the discovery of thrombosis in the intimidated patients. Meanwhile, the creators of the vaccine insist on its safety. The company stated that a detailed study of data on the state of health after vaccination was more than 17 million people showed the lack of increased risk of pulmonary artery embolism, deep vein thrombosis or thrombocytopenia.